Q4 EPS Estimates for Abacus Life Raised by Northland Capmk

Abacus Life, Inc. (NASDAQ:ABL) – Investment analysts at Northland Capmk boosted their Q4 2025 earnings per share (EPS) estimates for shares of Abacus Life in a research report issued on Friday, November 7th. Northland Capmk analyst M. Grondahl now anticipates that the company will post earnings of $0.22 per share for the quarter, up from their prior forecast of $0.21. The consensus estimate for Abacus Life’s current full-year earnings is $0.62 per share. Northland Capmk also issued estimates for Abacus Life’s Q1 2026 earnings at $0.23 EPS, Q2 2026 earnings at $0.26 EPS, Q3 2026 earnings at $0.28 EPS, Q4 2026 earnings at $0.29 EPS and FY2026 earnings at $1.05 EPS.

Abacus Life (NASDAQ:ABL) last released its quarterly earnings data on Thursday, November 6th. The company reported $0.20 earnings per share for the quarter, beating analysts’ consensus estimates of $0.18 by $0.02. Abacus Life had a return on equity of 17.01% and a net margin of 5.62%.The firm had revenue of $62.98 million during the quarter, compared to analyst estimates of $47.42 million.

Other equities analysts have also recently issued research reports about the stock. Weiss Ratings restated a “sell (e+)” rating on shares of Abacus Life in a research report on Wednesday, October 8th. Wall Street Zen raised Abacus Life from a “hold” rating to a “buy” rating in a research note on Saturday, August 9th. Finally, Piper Sandler reduced their price target on Abacus Life from $10.00 to $9.00 and set an “overweight” rating on the stock in a report on Thursday, October 9th. Three analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $12.67.

Abacus Life Trading Up 22.2%

NASDAQ:ABL opened at $6.45 on Monday. The company has a fifty day moving average of $5.98 and a 200 day moving average of $6.34. Abacus Life has a 52 week low of $4.60 and a 52 week high of $9.61. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.57. The firm has a market capitalization of $624.10 million, a P/E ratio of 80.63 and a beta of -0.02.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in ABL. AlphaQuest LLC purchased a new stake in Abacus Life in the second quarter worth $25,000. Darwin Wealth Management LLC bought a new stake in shares of Abacus Life during the 2nd quarter valued at $27,000. CWM LLC purchased a new stake in shares of Abacus Life in the 3rd quarter worth about $38,000. Raymond James Financial Inc. purchased a new stake in shares of Abacus Life in the 2nd quarter worth about $34,000. Finally, Legal & General Group Plc bought a new position in shares of Abacus Life in the 2nd quarter worth about $34,000.

Abacus Life Announces Dividend

The company also recently announced an annual dividend, which will be paid on Wednesday, December 17th. Shareholders of record on Tuesday, December 2nd will be issued a dividend of $0.20 per share. The ex-dividend date is Tuesday, December 2nd. This represents a dividend yield of 310.0%.

Abacus Life Company Profile

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.